Patient journeys in the era of COVID-19OPEN Health’s Richard Jones and Sumira Riaz assess the pandemic’s implications for understanding patients’ experiences and how the Share XPatient journeys in the era of COVID-19https://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/patient-journeys-in-the-era-of-covid-19/
OPEN Health Group promotes Rob Barker as CEORob Barker has been promoted to chief executive officer of Marlow, UK-based OPEN Health Group after serving as Share XOPEN Health Group promotes Rob Barker as CEOhttps://pharmaphorum.com/news/open-health-group-promotes-rob-barker-ceo/
Germany’s digital health changes will boost digital therapeutics in EuropeDigital therapeutics are gaining momentum worldwide and offer developers, including pharma, both a huge opportunity and a stimulating Share XGermany’s digital health changes will boost digital therapeutics in Europehttps://deep-dive.pharmaphorum.com/magazine/digital-health-innovation-2020/germanys-digital-health-changes-will-boost-digital-therapeutics/
Responding to dynamic shifts in value communicationsOPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means Share XResponding to dynamic shifts in value communicationshttps://deep-dive.pharmaphorum.com/magazine/communications-2020/responding-to-dynamic-shifts-in-value-communications/
Deep Dive: Communications 2020COVID-19 might have forced pharma to finally fully embrace digital comms, but it’s been a steep learning curve Share XDeep Dive: Communications 2020https://pharmaphorum.com/sales-marketing/deep-dive-communications-2020/
Commercialising innovative new medicinesAs pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination Share XCommercialising innovative new medicineshttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/commercialising-innovative-new-medicines/
Helping HCPs navigate the ever-evolving advanced cancer landscapeOPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can Share XHelping HCPs navigate the ever-evolving advanced cancer landscapehttps://deep-dive.pharmaphorum.com/magazine/future-of-oncology-2020/helping-hcps-navigate-the-ever-evolving-advanced-cancer-landscape/
Breaking barriers to patient access in rare oncologyAs technological advances unlock a more nuanced understanding of disease – and exciting opportunities for personalised medicine – Share XBreaking barriers to patient access in rare oncologyhttps://deep-dive.pharmaphorum.com/magazine/market-access-2020/breaking-barriers-to-patient-access-in-rare-oncology/
Jeff Anderson joins OPEN Health in European lead roleJeff Anderson has joined OPEN Health as European Lead for its OPEN VIE and Pharmerit Europe practices. In Share XJeff Anderson joins OPEN Health in European lead rolehttps://pharmaphorum.com/news/open-health-jeff-anderson-vie-pharmerit/
